Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapy

PURPOSE: The aim of this study was to demonstrate lipegfilgrastim superiority versus placebo in adults with non-small cell lung cancer receiving myelosuppressive chemotherapy. METHODS: This phase III, double-blind study randomized chemotherapy-naive patients to receive cisplatin and etoposide with e...

Descripción completa

Detalles Bibliográficos
Autores principales: Volovat, Constantin, Bondarenko, Igor M, Gladkov, Oleg A, Elsässer, Reiner, Buchner, Anton, Bias, Peter, Müller, Udo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489970/
https://www.ncbi.nlm.nih.gov/pubmed/26155455
http://dx.doi.org/10.1186/s40064-015-1067-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489970/
https://www.ncbi.nlm.nih.gov/pubmed/26155455
http://dx.doi.org/10.1186/s40064-015-1067-7

Ejemplares similares